跳至主要内容
临床试验/EUCTR2009-015077-12-GB
EUCTR2009-015077-12-GB进行中(未招募)1 期

The use of corticosteroids (Budenofalk) as a chemopreventative agent in ulcerative colitis associated neoplasia

niversity Hospital Birmingham NHS Foundation Trust0 个研究点目标入组 50 人开始时间: 2009年9月17日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • Symptimatic ulcerative pan-colitis (affecting the colon to at least the hepatic flexure) for more than 10 years
  • On active ulcerative colitis surveillance colonoscopy programme
  • Cortico-steroid naive (topical and systemic) for 6 months
  • Able to give informed consent
  • May be on miantenence 5ASA or immunosuppressant treatment which will be continued
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Previous colorectal adenocarcinoma
  • Known dysplasia in the colon
  • Ongoing corticosteroid use
  • Prior colonic surgical resection
  • Unable to give informed consent

研究者

发起方
niversity Hospital Birmingham NHS Foundation Trust

相似试验